
The Use of Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient With Novel Coronavirus 2019 Infection: A Case Report
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
The Use of Convalescent Plasma Therapy and Remdesivir in the Successful Management of a Critically Ill Obstetric Patient With Novel Coronavirus 2019 Infection: A Case Report
Subject
Description
Remdesivir is a novel therapeutic with known activity against SARS CoV-2 and related coronaviruses. Remdesivir, as well as convalescent plasma therapy, are currently under investigation as potential therapies for patients with Coronavirus Disease 19 (COVID-19).
Date
2020-05-16
Type
Citation
Anderson, Jonathon, Jordan Schauer, Suzanne Bryant, and Cornelia R. Graves. 2020. "The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report." Case Reports in Women's Health:e00221.
Abstract
Keywords
Remdesivir
Convalescent plasma
COVID-19
SARS CoV-2
Coronavirus
Pregnancy
Accessibility
Free online
Was this resource helpful?